Thursday, May 19, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home News

CellPort software joins the tetra partner network to help customers accelerate cell development and manufacturing

by Medical Finance
in News
Study provides valuable insight into the developmental origins of schizophrenia
9
SHARES
99
VIEWS
Share on FacebookShare on Twitter

TetraScience, the R&D Data Cloud company, announced today that CellPort Software, a SaaS company that digitizes workflows for cell development and manufacturing, has joined the Tetra Partner Network (TPN) to accelerate delivery of cell-based therapeutics.

We welcome a partnership with CellPort, recognizing their crucial contribution to eliminating paper lab notebooks in cell manufacturing processes. CellPort shares our unrelenting commitment to creating scientific data liquidity. Via this partnership, TetraScience’s platform easily connects laboratory products to CellPort’s software so that customers can quickly create innovative, new workflows and gain crucial insights into cell lines.”


Simon Meffan-Main, Ph.D, Vice President of Product, TPN

Cell culture plays a critical role in discovery and development of small and large molecule therapies, in vitro ADME and toxicity profiling, and gene and cell therapies. Cells are essential to the future of the life sciences in all its permutations. Still, working with cells has significant challenges to ensure robust processes and improved reproducibility because the data associated with them resides in paper notebooks or is locked in vendor-specific software. Because of this many therapeutics fail in late development and manufacturing, costing billions of dollars and wasting years of research.

Founded in 2014, CellPort has eliminated many of these problems and has been critical to the success of over 50 cell-based FDA-approved Biopharmaceutics Classifications Systems (BCS) biowaiver approvals. These biowavers represent regulatory approval based on the evidence of equivalence to in vivo (in body) testing, thus saving significant time and cost. CellPort’s SaaS suite combines the end-to-end laboratory inventory and process management of a LIMS (Laboratory Informatics Management System) with the highly repeatable QC and manufacturing focus of an LES (Laboratory Execution System).

The CellPort Cell Culture Suite spans research, GLP, and GMP with full audit-ready traceability of cell lineages, which provides desperately needed quality control while creating significant cost savings. We’re thrilled to become a member of the Tetra Partner Network. By collaborating with the creator of the life science industry’s de facto R&D data platform, we help customers accelerate the digital transformation of cell manufacturing, consistent with the U.S. FDA’s new initiative of the Office of Digital Transformation (ODT).”


Gregory M. Banik, Ph.D, Vice President of Operations, CellPort

The rapid growth of TPN reflects a surge of interest from customers and vendors to move scientific data into the TetraScience R&D Data Cloud. TPN provides partnership models that offer all industry vendors a means to create valuable, monetized, co-developed digital products.

Every partner added to the Tetra Partner Network creates value for customers. As partners and customers continue to accelerate adoption of our open platform, the entire life sciences industry works in lockstep, eliminating data silos and delivering unrestricted scientific data innovation.”


Patrick Grady, TetraScience Chairman, CEO

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

Phico Therapeutics establishes Scientific Advisory Board

Phico Therapeutics establishes Scientific Advisory Board

by Medical Finance
May 19, 2022
0

Phico Therapeutics Ltd (‘Phico’), a biotechnology company developing engineered phage technology as the basis of a new generation of antibiotics...

Scrapping many Covid testing measures is a grave mistake, says London Medical Laboratory

Win an EVOLVE Manual Pipette Starter Pack from INTEGRA

by Medical Finance
May 19, 2022
0

INTEGRA Biosciences is giving labs a chance to win one of 10 EVOLVE Manual Pipette Starter Packs. EVOLVE pipettes are...

AI-driven solution predicts RNA and DNA binding sites to accelerate rational drug discovery

New machine-learning model could speed up the process of developing new medicines

by Medical Finance
May 19, 2022
0

Antibodies, small proteins produced by the immune system, can attach to specific parts of a virus to neutralize it. As...

‘Lefty’ protein pumps the brakes during initial stages of embryo differentiation

Using ‘off-the-shelf’ engineered stem cell based therapy for treating glioblastomas post-surgery

by Medical Finance
May 19, 2022
0

Glioblastomas (GBMs) are highly aggressive cancerous tumors of the brain and spinal cord. Brain cancers like GBM are challenging to...

Omicron variant found to be much less sensitive to neutralizing antibodies than Delta

Omicron variant found to be much less sensitive to neutralizing antibodies than Delta

by Medical Finance
May 19, 2022
0

The Omicron variant was detected for the first time in South Africa in November 2021 and has since spread to...

Manipulating voltage patterns in tumor cells reduces breast cancer metastasis in animal models

Living human breast milk cells offer insight into breast cancer development

by Medical Finance
May 19, 2022
0

Researchers have explored the cellular changes that occur in human mammary tissue in lactating and non-lactating women, offering insight into...

Next Post
Nutritional components hold promise for improving the health and well-being of adults

Molecular RNA profile of naked mole-rats reveals new insights on skin aging

Study: Anisodamine potently inhibits SARS-CoV-2 infection in vitro and targets its main protease. Image Credit: SKK Pix / Shutterstock

Compound found in Datura shows promise as antiviral agent against SARS-CoV-2

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • ImageForNews 713023 16520914119402644
    Love Is in the air…detected by PTR-TOF
  • 3D illustration egg cells embryo. Embryo cells with red nucleuses in center. Hum Rost9 M1 3c512a7b78a9417e986aa778a4cf4559 620x480
    Study reveals role of a protein in healthy functioning of blood stem cells
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply